Page last updated: 2024-08-25

rosiglitazone and Cardiomyopathy, Congestive

rosiglitazone has been researched along with Cardiomyopathy, Congestive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldberg, IJ; Homma, S; Huang, LS; Huggins, LA; Okajima, K; Park, TS; Son, NH; Szabolcs, MJ; Yamashita, H; Yokoyama, M	1

Other Studies

1 other study(ies) available for rosiglitazone and Cardiomyopathy, Congestive

Article	Year
Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. The Journal of clinical investigation, 2007, Volume: 117, Issue:10 Topics: Aging; Animals; Cardiomyopathy, Dilated; Fatty Acids; Gene Expression; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Glycogen; Heart; Lipid Metabolism; Mice; Mice, Transgenic; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones; Ventricular Myosins	2007

Article

Year

Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.

The Journal of clinical investigation, 2007, Volume: 117, Issue:10

Topics: Aging; Animals; Cardiomyopathy, Dilated; Fatty Acids; Gene Expression; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Glycogen; Heart; Lipid Metabolism; Mice; Mice, Transgenic; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones; Ventricular Myosins

2007